loader
Please Wait
Applying Filters...
menu
    • menu

    Quality Alerts: Health Canada Issues Recall of Reddy-Dasatinib: out of specification - Dr. Reddy\'s Laboratories

    MenuDr. Reddy's Laboratories

    Uploaded: 2022
    News
    Cancer Drug Makers Seek 50% Price Hike Amid Platinum Surge

    06 Apr 2026

    // ECONOMICTIMES

    Dr Reddy’s Generics Nintedanib Esylate Receives Approval in US

    02 Apr 2026

    // FDA

    Corona Remedies Unveils Wokadine Initiative in India

    31 Mar 2026

    // EXPRESSPHARMA

    DATA COMPILATION
    #PharmaFlow

    DRL VB RM

    Contact Supplier

    Website

    MAGHREB Pharma Expo

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-pharmareel/dr-reddys-laboratories/leading-supplier-of-apis-for-40-years
    Xls

    CATEGORY PAGE
    Menu

    Dr. Reddy's Laboratories

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC100302
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.